SHSE:688366'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.89 Med: 9.69 Max: 17.05
Current: 9.27
During the past 11 years, Shanghai Haohai Biological Technology Co's highest Return-on-Tangible-Equity was 17.05%. The lowest was 3.89%. And the median was 9.69%.
SHSE:688366's Return-on-Tangible-Equity is ranked better than 86.01% of 1258
companies
in the Biotechnology industry
Industry Median: -43.075
vs SHSE:688366: 9.27
Shanghai Haohai Biological Technology Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shanghai Haohai Biological Technology Co Return-on-Tangible-Equity Chart
Shanghai Haohai Biological Technology Co Annual Data
Competitive Comparison of Shanghai Haohai Biological Technology Co's Return-on-Tangible-Equity
For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Haohai Biological Technology Co's Return-on-Tangible-Equity Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Shanghai Haohai Biological Technology Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2024) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
Shanghai Haohai Biological Technology Co (SHSE:688366) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Shanghai Haohai Biological Technology Co Return-on-Tangible-Equity Related Terms
Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.
Shanghai Haohai Biological Technology Co Business Description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHSE:688366 has been successfully added to your 